Cargando…

Antituberculosis Drug‐Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors

Antituberculosis drug‐induced adverse drug reactions (ATD‐ADRs) are increasing globally, and it is key to identify candidate ATD‐ADRs loci for clinical management. We prospectively enrolled 1,235 highly suspicious tuberculosis (TB) inpatients to investigate the profiles and genetic risk factors of A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xuejiao, Zhang, Mei, Bai, Hao, Wu, Lijuan, Chen, Yanqing, Ding, Liu, Zhao, Zhenzhen, Peng, Wu, Liu, Tangyuheng, Song, Jiajia, Li, Yinyu, Lu, Xiaojun, Chen, Xuerong, Zhou, Yanhong, Ying, Binwu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099196/ https://www.ncbi.nlm.nih.gov/pubmed/29071720 http://dx.doi.org/10.1002/cpt.924

Ejemplares similares

Genetic polymorphisms of long noncoding RNA RP11‐37B2.1 associate with susceptibility of tuberculosis and adverse events of antituberculosis drugs in west China
por: Song, Jiajia, et al.
Publicado: (2019)

Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity
por: Zhang, Jingwei, et al.
Publicado: (2021)

The Variant at TGFBRAP1 but Not TGFBR2 Is Associated with Antituberculosis Drug-Induced Liver Injury
por: Zhang, Jingwei, et al.
Publicado: (2019)

Interleukin‐21 receptor gene polymorphism is associated with hepatitis B virus‐related hepatocellular carcinoma in Chinese patients
por: Liu, Tangyuheng, et al.
Publicado: (2019)

TLR1 polymorphisms are significantly associated with the occurrence, presentation and drug-adverse reactions of tuberculosis in Western Chinese adults
por: Peng, Wu, et al.
Publicado: (2017)

Genome‐wide association study of tuberculosis in the western Chinese Han and Tibetan population
por: Bai, Hao, et al.
Publicado: (2023)

Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
por: Zhang, Jingwei, et al.
Publicado: (2019)

A case-control study on correlation between the single nucleotide polymorphism of CLEC4E and the susceptibility to tuberculosis among Han people in Western China
por: Zhou, Wenjing, et al.
Publicado: (2021)

No Significant Effect of ASAP1 Gene Variants on the Susceptibility to Tuberculosis in Chinese Population
por: Hu, Xuejiao, et al.
Publicado: (2016)

Screening of Long Non-coding RNAs Biomarkers for the Diagnosis of Tuberculosis and Preliminary Construction of a Clinical Diagnosis Model
por: Chen, Juli, et al.
Publicado: (2022)

Clinical relevance of the lnc‐HNF1B‐3:1 genetic polymorphisms in Western Chinese tuberculosis patients
por: Wu, Qian, et al.
Publicado: (2019)

Integrating exosomal microRNAs and electronic health data improved tuberculosis diagnosis
por: Hu, Xuejiao, et al.
Publicado: (2019)

Diagnosis of Hypersensitivity Induced by Antituberculosis Drugs
por: Wu, Yuqing, et al.
Publicado: (2021)

The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study
por: Lyu, Mengyuan, et al.
Publicado: (2019)

Pathway Analyses Identify Novel Variants in the WNT Signaling Pathway Associated with Tuberculosis in Chinese Population
por: Hu, Xuejiao, et al.
Publicado: (2016)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins
por: Arrigoni, Elena, et al.
Publicado: (2017)

Long Noncoding RNA and Predictive Model To Improve Diagnosis of Clinically Diagnosed Pulmonary Tuberculosis
por: Hu, Xuejiao, et al.
Publicado: (2020)

Adverse Reactions to Antituberculosis Drugs in Iranian Tuberculosis Patients
por: Farazi, Aliasghar, et al.
Publicado: (2014)

Risk factors associated with adverse reactions to antituberculosis drugs
por: Resende, Laíse Soares Oliveira, et al.
Publicado: (2015)

Epidemiological surveillance of common respiratory viruses in patients with suspected COVID-19 in Southwest China
por: Si, Yanjun, et al.
Publicado: (2020)

Adverse drug reaction profile of daily regimen antituberculosis treatment
por: Sankar, K. N. Hari, et al.
Publicado: (2022)

Clinical features, Outcomes and Molecular Profiles of Drug Resistance in Tuberculous Meningitis in non-HIV Patients
por: Zhang, Jingya, et al.
Publicado: (2016)

Clinical relevance of LINC00152 and its variants in western Chinese tuberculosis patients
por: Li, Jing, et al.
Publicado: (2017)

Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone
por: Ali, Samina, et al.
Publicado: (2023)

Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
por: Damasceno, Glauciene Santana, et al.
Publicado: (2013)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines
por: Jennings, Barbara A., et al.
Publicado: (2013)

P25 - Hypersensitivity/adverse reactions to antituberculosis drugs – a case report
por: Barrosa Maia, Estefânia, et al.
Publicado: (2014)

Correction: Evaluating Predictive Pharmacogenetic Signatures of Adverse Events in Colorectal Cancer Patients Treated with Fluoropyrimidines
por: Jennings, Barbara A., et al.
Publicado: (2015)

Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study
por: de Miguel, Laura, et al.
Publicado: (2023)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Cutaneous adverse drug reactions in patients with peripheral blood eosinophilia during antituberculosis treatment
por: Kim, Tae-Ok, et al.
Publicado: (2019)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Acquired Resistance to Antituberculosis Drugs
por: Aung, Htin Lin, et al.
Publicado: (2018)

Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on Standard of Care Treatment in Zimbabwe
por: Afolabi, Boluwatife Lawrence, et al.
Publicado: (2023)

Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China: A Cross-sectional Study
por: Ye, Yuanxin, et al.
Publicado: (2016)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Association of PXR and CAR Polymorphisms and Antituberculosis Drug-Induced Hepatotoxicity
por: Wang, Yu, et al.
Publicado: (2019)

Antituberculosis drug-induced hepatotoxicity in children
por: Donald, Peter R
Publicado: (2011)

Population Pharmacokinetics of the Antituberculosis Agent Pretomanid
por: Salinger, David H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jpv4rdo7vuajk3asom2g66h0br